222 related articles for article (PubMed ID: 1268065)
1. The effect of clobetasone butyrate and other topical steroids on skin thickness of the domestic pig.
Winter GD; Wilson L
Br J Dermatol; 1976 May; 94(5):545-50. PubMed ID: 1268065
[TBL] [Abstract][Full Text] [Related]
2. Measurement of dermal atrophy induced by topical steroids using a radiographic technique.
James MP; Black MM; Sparkes CG
Br J Dermatol; 1977 Mar; 96(3):303-5. PubMed ID: 322693
[TBL] [Abstract][Full Text] [Related]
3. Experimentally induced steroid atrophy in the domestic pig and man.
Winter GD; Burton JL
Br J Dermatol; 1976 Mar; 94 suppl 12():107-9. PubMed ID: 1268070
[TBL] [Abstract][Full Text] [Related]
4. Clobetasone butyrate, a new topical corticosteroid: clinical activity and effects on pituitary-adrenal axis function and model of epidermal atrophy.
Munro DD; Wilson L
Br Med J; 1975 Sep; 3(5984):626-8. PubMed ID: 1164639
[TBL] [Abstract][Full Text] [Related]
5. A separation of clinical from epidermal thinning effect in the topical glucocorticoid clobetasone butyrate.
Stevanovic DV; Wilson L; Sparkes CG
Br J Dermatol; 1977 Jan; 96(1):67-70. PubMed ID: 320995
[TBL] [Abstract][Full Text] [Related]
6. Objective measurement of topically applied corticosteroids.
Király K; Soós G
Dermatologica; 1976; 152 Suppl 1():133-7. PubMed ID: 955233
[TBL] [Abstract][Full Text] [Related]
7. Bio-assay of corticosteroids for topical application.
Spearman RI; Jarrett A
Br J Dermatol; 1975 May; 92(5):581-4. PubMed ID: 1174471
[TBL] [Abstract][Full Text] [Related]
8. [Pharmacology of dermatocorticoids (2. Continuation)].
Weirich EG
Z Hautkr; 1978 Apr; 53(7):209-16 contd. PubMed ID: 645170
[No Abstract] [Full Text] [Related]
9. Epidermal thinning: evaluation of commercial corticosteroids.
Wrench R
Arch Dermatol Res; 1980; 267(1):7-24. PubMed ID: 7387177
[TBL] [Abstract][Full Text] [Related]
10. Desonide, a potent nonfluorinated topical steroid, vasoconstriction assay and clinical trial.
Smith EB; Gregory JF; Bartruff JK
South Med J; 1973 Mar; 66(3):325-9. PubMed ID: 4570656
[No Abstract] [Full Text] [Related]
11. Bioassay system for formulations of topically applied glucocorticosteroids.
Stoughton RB
Arch Dermatol; 1972 Dec; 106(6):825-7. PubMed ID: 4639246
[No Abstract] [Full Text] [Related]
12. Topical retinoic acid does not alter the vasoconstrictive properties of topical corticosteroids in humans.
Schmied C; Saurat JH
Dermatologica; 1991; 182(2):107-11. PubMed ID: 2050230
[TBL] [Abstract][Full Text] [Related]
13. Steroid-induced atrophy in an animal and human model.
Kirby JD; Munro DD
Br J Dermatol; 1976 Mar; 94 suppl 12():111-9. PubMed ID: 1268071
[TBL] [Abstract][Full Text] [Related]
14. [Skin vasoconstriction assay in the evaluation of topical corticosteroids in man. General problems and results obtained in a series of tests (author's transl)].
Weirich EG; Lutz U
Dermatologica; 1973; 147(6):353-75. PubMed ID: 4788215
[No Abstract] [Full Text] [Related]
15. The effect of corticosteroids on human epidermal mitotic activity.
Fisher LB; Maibach HI
Arch Dermatol; 1971 Jan; 103(1):39-44. PubMed ID: 4321801
[No Abstract] [Full Text] [Related]
16. The evaluation of a novel corticosteroid formulation, fluocinonide in "FAPG" base, in the blanching test.
Coldman MF; Lockerbie L; Laws EA
Br J Dermatol; 1971 Dec; 85(6):573-6. PubMed ID: 4947552
[No Abstract] [Full Text] [Related]
17. Utilization of epidermal phospholipase A2 inhibition to monitor topical steroid action.
Norris JF; Ilderton E; Yardley HJ; Summerly R; Forster S
Br J Dermatol; 1984 Jul; 111 Suppl 27():195-203. PubMed ID: 6743552
[TBL] [Abstract][Full Text] [Related]
18. The influence of corticosteroids, griseofulvin and tolnaftate on the in vitro growth of two dermatophytes.
Caplan RM; Clabaugh W
J Invest Dermatol; 1969 Mar; 52(3):247-54. PubMed ID: 5774352
[No Abstract] [Full Text] [Related]
19. Topical corticosteroids.
Pace WE
Can Med Assoc J; 1973 Jan; 108(1):ll passim. PubMed ID: 4682644
[No Abstract] [Full Text] [Related]
20. Paired comparison vasoconstrictor assays. A comparison of methods for the determination of relative vasoconstrictor potency of topically applied corticosteroids.
Poulsen BJ; Burdick K; Bessler S
Arch Dermatol; 1974 Mar; 109(3):367-71. PubMed ID: 4814938
[No Abstract] [Full Text] [Related]
[Next] [New Search]
